1 Manolagas SC, Hustmyer FG, Yu XP. 1, 25-Dihydroxyvitamin D3 and the immune system. Proc Soc Exp Biol Med,1989, 191:238. 2 Milde P, Hauser U, Simon T, et al. Expression of 1, 25-dihy-droxyvitamin D3 receptorsin normal and psoriatic skin.J Invest Dermatol, 1991, 97:230. 3 Holick M F. Will 1, 25-dihydroxyvitamin D3, MC903, and their analogues herald a new pharmacologicera for the treatment of psoriasis? Arch Dermatol, 1989, 125:1692. 4 Sauder D N. Therole of epidermal cytokines in inflammatory skin diseases. J Invest Dermatol, 1990, 95:227s. 5 Schroder J M,Christopher E.Identification of a novel family of highly potentneutrophil chemotactic peptides in psoriatic scales (Abstract). J Invest Dermatol, 1988, 91:395. 6 Kaneko F,Ito N,Yoshita H,et al.The cell components and cytokines in the subcorneal microabscess of psoriasis. Fukushima J Med Sci, 1991, 37:103. 7 Nicholoff BJ, Karabin GD, Barker JN WN, et al. Cellular localization of interleu kin-8 and its inducer,tumornecros is factoral pha in psoriasis. Am J Pathol, 1991, 138:129. 8 张建中, 丸山幸治, 金子史男. 前殖腺素 E1对角朊细胞和真皮纤维母细胞增殖及细胞因子产生的影响. 中华皮肤科杂志, 1996, 29:27. |